Glenmark Life Sciences IPO GMP Today, Live IPO Grey Market Premium 2021

Glenmark Life Sciences IPO GMP is very attractive to date. Here in the below tables, you can check Glenmark Life Sciences IPO GMP, Kostak, and Subject rates. Grey Market premium for Glenmark Life Sciences is around ₹100.

The Glenmark Life Sciences IPO will hit the market soon, and you can apply for the IPO from 27th July to 29th July 2021. Glenmark Life Sciences is planning to raise ₹1,513.60 Crores through an IPO which consists of fresh issue of ₹1,060 crores worth equity and OFS (Offer For Sale) of 6,300,000 equity shares by Glenmark Pharmaceuticals. Also, check IPO GMP for upcoming IPOs.

Latest Glenmark Life Sciences IPO GMP- 

Glenmark Life Sciences IPO GMP table is updated every day to give you the exact grey market premium for Glenmark Life Sciences IPO.

DateIPO GMP Kostak RatesSubject to Sauda
6/08/2021 ₹85 ₹300 ₹1200
5/08/2021 ₹90 ₹300 ₹1200
4/08/2021 ₹80 ₹300 ₹1200
3/08/2021 ₹100 ₹300 ₹1200
2/08/2021 ₹110 ₹300 ₹1200
30/07/2021 ₹150 ₹300 ₹1200
29/07/2021 ₹130 ₹300 ₹1200
28/07/2021 ₹120 ₹300 ₹1200
27/07/2021 ₹130
26/07/2021 ₹140
25/07/2021 ₹145
24/07/2021 ₹125
23/07/2021 ₹195

Should you subscribe to Glenmark Life Sciences IPO?

We have researched and mentioned the strengths and risks of the Glenmark Life Sciences IPO. The final verdict will help you make the right decision.

Strength – 

  • Leading producer of APIs for chronic therapeutics like pain management, CVS, and CNS. 
  • Export products in Latin America, Japan, Europe, North America and the rest of the world. 
  • Strong relationships with the world’s leading pharmaceutical companies.
  • Quality product manufacturing with the 
  • Promising financial track record.

Risks – 

  • Suspension, Slowdown or decrease in availability of material can cause harm to financial numbers. 
  • Increase in cost of raw materials can cause a huge impact on their operating profits. 
  • Failure to meet the standard norms of Indian Government or International Government can be a major risk to their products.

Final Verdict – 

They are Leading producers of APIs for chronic therapeutics like pain management, CVS, and CNS. In a short span of time, Glenmark Life Sciences have achieved rapid growth due to their strong connections and quality production. They export to 540 pharma companies worldwide which shows they have a large versatile client base. As an investor, this gives us the confidence to bet on Glenmark Life Sciences.

Investors can invest for the long term in the Glenmark Life Sciences IPO. It’s early to predict but Glenmark Life Sciences IPO can give great listing gains by seeing its grey market premium. You can read the details of the Glenmark Life Sciences IPO here.

Glenmark Life Sciences IPO Dates & Price Band:

Open date27th July 2021
Close date29th July 2021
Total Size of IPO₹1,513.60 Cr.
Fresh Issue 1,060 Cr.
Offer for Sale6,300,000 equity shares
Price Band₹695 – 720
Face Value₹2 per share
Listing onNSE and BSE
Retail Investor’s Portion35%

Glenmark Life Sciences IPO Market Lot:

The minimum market lot of Glenmark Life Sciences IPO is 13 shares with 14,400 applications. Retail investors can apply for 13 lots with 260 shares application worth 1,87,200.

ApplicationLotSharesCut Off Amount
Minimum (RII)12014,400
Maximum (NII)132601,87,200

Glenmark Life Sciences IPO Allotment & Listing Dates:

Glenmark Life Sciences IPO’s open date is 27th July and the closing date is 29th July. Allotment of shares will be done on 3rd August and the listing date on NSE & BSE is 6th August 2021.

Allotment Date for Glenmark Life Sciences – 3rd August 2021
Refund Date for Glenmark Life Sciences – 4th August 2021
Credit of Shares to Demat Account – 5th August 2021
Listing Date for Glenmark Life Sciences – 6th August 2021

About Glenmark Life Sciences:

Glenmark Life Sciences is an API arm of Glenmark Pharmaceuticals Limited. They work with the top 16 pharmaceutical firms globally and bring creativity and operating efficiency to meet customer needs. In total, they have 120 APIs in their portfolio. 

Their massive production and research facilities allow them to deliver the best services. They are Leading producers of APIs for chronic therapeutics like pain management, CVS, and CNS. Having strong connections with other pharma companies has helped us to export our products to Latin America, Japan, Europe, North America, and the rest of the world.

Competitor’s Comparison –

Sr.No.Company NamePE 
1Divi’s Laboratories Ltd72.9
2Laurus Labs Ltd18.21
3Shilpa Medicare Ltd19.62
4Aarti Drugs Ltd11.65
5Solara Active Pharma Sciences Ltd33.24

Glenmark Life Sciences IPO GMP FAQs:


What is the Glenmark Life Sciences IPO GMP today?

Glenmark Life Sciences IPO GMP is ₹85 as of today.

What is the last date to apply for Glenmark Life Sciences IPO?

29th July 2021 is the last date to apply for Glenmark Life Sciences IPO.

What is Kostak Rates of Glenmark Life Sciences IPO today?

Glenmark Life Sciences IPO Kostak Rates is ₹300 as of today.

Will Glenmark Life Sciences IPO GMP increase?

It’s too early to say that but we can expect a good premium on Glenmark Life Sciences IPO.

Can Glenmark Life Sciences give listing gains?

Investors can invest for the long term in the Glenmark Life Sciences IPO. It’s early to predict but Glenmark Life Sciences IPO GMP can give great listing gains by seeing its. You can keep a track of Glenmark Life Sciences IPO GMP here. 


Disclaimer for Investors:

  • We on ipogmp.in do not buy or sell any kind of IPO forms.  
  • Do not subscribe to IPO just by seeing its GMP. You should do proper research about the fundamentals of a company.
  • IPO GMP changes every day and you can view the changes in the above table.
  • Always apply to an IPO after understanding financials and discussing with your financial advisor.
Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *